Josh Warren
Primary Care · Birmingham, ALNPI 1205378551
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $5,571 of the $9,041 with a category attached, or 61.6%. Inspire Medical Systems, Inc. accounts for 66.6% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $3,024, 2.9 times the $1,040 reported in 2021. Among primary care clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 60 payments — averaging $150.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$6K
- ZOLL Respicardia, Inc.$2K
- Jazz Pharmaceuticals Inc.$680
- Harmony Biosciences LLC$180
- Abbott$35
- Abiomed$33
- plus $54 from 2 others
What the payments were for
- Consulting fees$6808%
- Travel & lodging$5,57162%
- Food & beverage$2,69930%
- Education$901%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 48 | $6,025 |
| ZOLL Respicardia, Inc. | 2 | $2,033 |
| Jazz Pharmaceuticals Inc. | 1 | $680 |
| Harmony Biosciences LLC | 4 | $180 |
| Abbott | 2 | $35 |
| Abiomed | 1 | $33 |
| 3b Medical, Inc. | 1 | $31 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$4,286
- remede System$1,961
- Inspire Upper Airway Stimulation System$905
- SUNOSI$680
How this compares
$9,041 in reported general payments places this provider in the 95th percentile of 159 primary care providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ropinirole ErRopinirole Hcl | 21 | $2,004 |
| Trazodone Hcl | 149 | $1,376 |
| Doxepin Hcl | 69 | $957 |
| Ropinirole Hcl | 42 | $553 |
| Azelastine Hcl | 15 | $412 |
| Fluticasone Propionate | 23 | $367 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 15 | $237 |
Paid to pharmacies, not to this prescriber.
Other primary care in Birmingham
- Jill AroraBirmingham$6K
- Bevin EllenbergBirmingham$5K
- Samantha WilliamsBirmingham$4K
- Barbara BoreenBirmingham$4K
- Joanna ReavesBirmingham$3K
- Anna MesserBirmingham$2K
- Hannah WuisanBirmingham$2K
- Tiffany LasernaBirmingham$2K
- Holly StraussBirmingham$2K
- Brooke LittleBirmingham$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.